Search
for

    Sort by

    Research 931–960 of 1000+

    1. Formulation and evaluation of self-nanoemulsifying drug delivery system for improved oral delivery of exemestane hydrochloride IP International Journal of Comprehensive and Advanced Pharmacology · 2023 · 4 citations
    2. Azathioprine‐induced severe myelosuppression accompanied by massive hair loss and painful oral ulcer in an autoimmune hepatitis patient with <i>NUDT15</i> minor variant: A case report Clinical Case Reports · 2021 · 3 citations
    3. Photodynamic therapy as a new therapeutic approach of oral lichen planus Journal of Mind and Medical Sciences · 2019 · 3 citations
    4. Induction and reversal of pulmonary lipid histiocytosis in rats following oral administration of anorectics cloforex and chlorphentermine Journal of Toxicology and Environmental Health · 1981 · 3 citations
    5. The Role of Vitamin D3 Deficiency and Colonization of the Oral Mucosa by Candida Yeast-like Fungi in the Pathomechanism of Psoriasis Journal of Clinical Medicine · 2024 · 2 citations
    6. [Artículo traducido] Efectos adversos graves por errores de formulación de minoxidil oral a bajas dosis para el tratamiento de la alopecia Actas Dermo-Sifiliográficas · 2022 · 2 citations
    7. Versatility of the inferiorly based nasolabial flap for reconstruction in early oral cancer patients: Our experience in a tertiary cancer centre International Journal of Otorhinolaryngology and Head and Neck Surgery · 2020 · 2 citations
    8. Improvement in Scalp Hair in Middle Aged Women Using Oral Enzyme Food and Collagen Jounal of The Korean Society of cosmetology · 2015 · 2 citations
    9. Two Cases of Reversible Bilateral Painful Gynecomastia Induced by 1mg Oral Finasteride(Propecia$^{(R)})$ Journal of Clinical Dermatology · 2003 · 2 citations
    10. Effective Treatment of Folliculitis Decalvans With a Combination of Oral Isotretinoin and Rifampicin Cureus · 2024 · 1 citations
    11. Achievement of good long-term control with direct oral anticoagulant for Buerger’s disease European Journal of Dermatology · 2023 · 1 citations
    12. [Retracted] Mechanism of Anti‐Inflammatory Drugs in the Early Treatment of Oral Gingival Mucosa and Soft Tissue Trauma Contrast Media & Molecular Imaging · 2022 · 1 citations
    13. Recent Advances in Cold Atmospheric Plasma for the Treatment of Oral Diseases Journal of Evidence-Based Medicine · 2026
    14. Simultaneous Versus Delayed Initiation of Spironolactone and Low‐Dose Oral Minoxidil: Adverse Event Rates in a Retrospective Cohort Study International Journal of Dermatology · 2026
    15. 76221 Faster Onset and Superior Efficacy of an Investigational Extended-Release Oral Minoxidil Tablet (VDPHL01) Versus Topical and Immediate-Release Oral Minoxidil for Androgenetic Alopecia: Results from a Blinded Retrospective Investigator Global Assessment Journal of the American Academy of Dermatology · 2026
    16. A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata Indian Dermatology Online Journal · 2026
    17. Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study" Mendeley Data · 2026
    18. Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study" Mendeley Data · 2026
    19. Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study" Mendeley Data · 2026
    20. Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia" Mendeley Data · 2026
    21. Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia" Mendeley Data · 2026
    22. Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial British Journal of Dermatology · 2026
    23. Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study Mendeley Data · 2026
    24. Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study Mendeley Data · 2026
    25. Comparative Evaluation of the Efficacy and Safety of Oral Finasteride versus Oral Dutasteride in Male Androgenetic Alopecia: An 18-Month Prospective Interventional Study from a Tertiary Care Centre in Uttar Pradesh International Journal of Medical and All Body Health Research · 2026
    26. Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database 2025
    27. BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata British Journal of Dermatology · 2025
    28. P075 A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata British Journal of Dermatology · 2025
    29. Comparing the Efficacy of Weekly Azathioprine Pulse versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata Pakistan Journal of Health Sciences · 2025
    30. Trachyonychia secondary to pediatric alopecia areata responding to oral tofacitinib therapy: a case report and review of literature International Journal of Dermatology · 2025